Use access key #2 to skip to page content.
$21.89 0.21 (0.97%)
7/23/2008 4:01 PM

Bristol-Myers Squibb Co. (BMY)

CAPS Rating:
****

The Company, through its divisions and subsidiaries, is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and other health care related products.

View All Commentary (BMY)

Recs

0

Avatar atlasbooks (67.87) Submitted: 5/06/08 7:27 AM : Outperform Start Price: $23.60 BMY Score: -9.27

Cramer pick for yesterday. Says it's win-win investing. Room for growth while paying 5% dividend. They may spin off part of their nutritional division- Mead Johnson and start aquiring small pharmas to add to their pipeline. Analyst meeting is today. Stay tuned.

Report this Post Replies: 0 | Reply

Featured Broker Partners